Ftse Mib
37.074,25
-0,13%
DAX
21.854,98
-0,26%
S&P 500
6.071,21
-0,20%
NASDAQ
19.652,01
-0,71%
Bitcoin
98.308,47
1,79%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Ginkgo Bioworks Holdings Inc (DNA) Ginkgo Bioworks Holdings Inc (DNA) Notizie

DNA

Ginkgo Bioworks (DNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:DNA
DataOraFonteTitoloSimboloCompagnia
06/02/202516:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
06/02/202514:01PR Newswire (US)Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference SeriesNYSE:DNAGinkgo Bioworks Holdings Inc
23/01/202514:01PR Newswire (US)Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)NYSE:DNAGinkgo Bioworks Holdings Inc
13/01/202514:01PR Newswire (US)Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid TumorsNYSE:DNAGinkgo Bioworks Holdings Inc
09/01/202514:00PR Newswire (US)Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:DNAGinkgo Bioworks Holdings Inc
17/12/202414:11PR Newswire (US)Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT ProgramNYSE:DNAGinkgo Bioworks Holdings Inc
12/11/202423:01PR Newswire (US)Ginkgo Bioworks Reports Third Quarter 2024 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
12/11/202414:01PR Newswire (US)Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics ManufacturingNYSE:DNAGinkgo Bioworks Holdings Inc
08/11/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
08/11/202423:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
05/11/202413:00PR Newswire (US)Ginkgo Bioworks Announces Date of Third Quarter 2024 Results PresentationNYSE:DNAGinkgo Bioworks Holdings Inc
24/09/202413:01PR Newswire (US)NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal AgricultureNYSE:DNAGinkgo Bioworks Holdings Inc
18/09/202413:01PR Newswire (US)Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in BiologyNYSE:DNAGinkgo Bioworks Holdings Inc
17/09/202414:01PR Newswire (US)Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud TechnologyNYSE:DNAGinkgo Bioworks Holdings Inc
04/09/202422:30PR Newswire (US)Ginkgo Regains Compliance with NYSE Minimum Bid Price RequirementNYSE:DNAGinkgo Bioworks Holdings Inc
30/08/202413:00PR Newswire (US)Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNYSE:DNAGinkgo Bioworks Holdings Inc
19/08/202422:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
09/08/202411:48IH Market NewsSweetgreen Rises 22% on Raised Forecasts, Doximity Jumps 30%, Rocket Lab Soars 14% on 71% Revenue Growth, and MoreNYSE:DNAGinkgo Bioworks Holdings Inc
08/08/202423:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DNAGinkgo Bioworks Holdings Inc
08/08/202423:03Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:DNAGinkgo Bioworks Holdings Inc
08/08/202423:01PR Newswire (US)Ginkgo Bioworks Reports Second Quarter 2024 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
02/08/202413:00PR Newswire (US)Ginkgo Bioworks to Hold Special Meeting of ShareholdersNYSE:DNAGinkgo Bioworks Holdings Inc
01/08/202413:01PR Newswire (US)Ginkgo Bioworks Announces Date of Second Quarter 2024 Results PresentationNYSE:DNAGinkgo Bioworks Holdings Inc
16/07/202413:01PR Newswire (US)Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicalsNYSE:DNAGinkgo Bioworks Holdings Inc
20/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202422:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202413:01PR Newswire (US)Ginkgo Bioworks to Participate in Two Conferences in MayNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202400:00PR Newswire (US)Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanNYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202422:05PR Newswire (US)Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSENYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202423:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:DNAGinkgo Bioworks Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:DNA

La tua Cronologia

BIT
NSCIT0558436
Republic of Italy
BIT
P19FS4
BNP Paribas Issuance
BIT
UV4KSW
UniCredit Bank
BIT
P1LSL7
BNP Paribas Issuance
BIT
P1WSS9
NLBNPIT1WSS9 20250620 33...
BIT
RKT
Roket Sharing
BIT
BFF
BFF Bank
EU
BE6355039841
Wallonne Bond Frn 27aug2...
BIT
NSCIT0539436
Gpi
AQSE
XGLS.GB
DB ETC
BIT
F39582
Vontobel Financial Produ...
BIT
S29299
Societe Generale Effekten
BIT
S7LCOA
Societe Generale Effekten
BIT
UC6M18
Unicredit Bank
BIT
P1S6L5
BNP Paribas Issuance
BIT
S31872
Societe Generale Effekten
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci